Vical Inc (VICL)

2.36
NASDAQ : Health Care
Prev Close 2.36
Day Low/High 2.33 / 2.38
52 Wk Low/High 2.05 / 4.80
Avg Volume 101.20K
Exchange NASDAQ
Shares Outstanding 11.10M
Market Cap 26.19M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Vical's Phase 1/2 Trial Data Presented At ASM 2016 Shows Bivalent Vaccine Imparts Reduction In Genital Herpes Lesions Durable To 9 Months

Vical's Phase 1/2 Trial Data Presented At ASM 2016 Shows Bivalent Vaccine Imparts Reduction In Genital Herpes Lesions Durable To 9 Months

Vical plans to advance the bivalent vaccine to a Phase 2 trial in 2016 and maintains current financial guidance for 2016